A. V. Ardabili and S. F. Sarabi, “Correlation between the elevated level of interleukin-6 following actemra administration and the mortality rate of seven severe COVID-19 patients”, Int J Community Med Public Health, vol. 11, no. 5, pp. 2037–2040, Apr. 2024.